Cardiac myosin inhibitor, mavacamten, improves myocardial relaxation in mouse HFpEF model

30 April 2022 (13:20 - 14:00)
Organised by: Logo
Congress Presentation Part of: Moderated poster 10 - Heart Failure Heart Failure CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

ESC 365 is supported by

ESC 365 is supported by